{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:40:27Z","timestamp":1707525627259},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,14]]},"DOI":"10.7759\/cureus.52238","type":"journal-article","created":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T09:20:56Z","timestamp":1705224056000},"source":"Crossref","is-referenced-by-count":0,"title":["Analgesic Effect of the Kampo Formula Yokukansan via the Suppression of Substance P in an Experimental Rat Model of Hunner-Type Interstitial Cystitis"],"prefix":"10.7759","author":[{"given":"Yoshiki","family":"Tsunokawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mana","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Tamaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Mugita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oyunchimeg","family":"Chuluunbat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Fukagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Sunagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14234","article-title":"Clinical guidelines for interstitial cystitis\/bladder pain syndrome","volume":"27","author":"Homma Y","year":"2020","unstructured":"Homma Y, Akiyama Y, Tomoe H, et al.. Clinical guidelines for interstitial cystitis\/bladder pain syndrome. Int J Urol. 2020, 27:578-89. 10.1111\/iju.14234","journal-title":"Int J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002756","article-title":"Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome","volume":"208","author":"Clemens JQ","year":"2022","unstructured":"Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol. 2022, 208:34-42. 10.1097\/JU.0000000000002756","journal-title":"J Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14229","article-title":"Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives","volume":"27","author":"Akiyama Y","year":"2020","unstructured":"Akiyama Y, Luo Y, Hanno PM, Maeda D, Homma Y. Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives. Int J Urol. 2020, 27:491-503. 10.1111\/iju.14229","journal-title":"Int J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2142084.042","article-title":"Current understanding and future perspectives of interstitial cystitis\/bladder pain syndrome","volume":"25","author":"Ueda T","year":"2021","unstructured":"Ueda T, Hanno PM, Saito R, Meijlink JM, Yoshimura N. Current understanding and future perspectives of interstitial cystitis\/bladder pain syndrome. Int Neurourol J. 2021, 25:99-110. 10.5213\/inj.2142084.042","journal-title":"Int Neurourol J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1039\/d0tb02094j","article-title":"Biomaterial-assisted drug delivery for interstitial cystitis\/bladder pain syndrome treatment","volume":"9","author":"Lin Z","year":"2021","unstructured":"Lin Z, Hu H, Liu B, Chen Y, Tao Y, Zhou X, Li M. Biomaterial-assisted drug delivery for interstitial cystitis\/bladder pain syndrome treatment. J Mater Chem B. 2021, 9:23-34. 10.1039\/d0tb02094j","journal-title":"J Mater Chem B"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0891-0618(00)00115-0","article-title":"Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis","volume":"21","author":"Vizzard MA","year":"2001","unstructured":"Vizzard MA. Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis. J Chem Neuroanat. 2001, 21:125-38. 10.1016\/s0891-0618(00)00115-0","journal-title":"J Chem Neuroanat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/120525","article-title":"The role(s) of cytokines\/chemokines in urinary bladder inflammation and dysfunction","volume":"2014","author":"Gonzalez EJ","year":"2014","unstructured":"Gonzalez EJ, Arms L, Vizzard MA. The role(s) of cytokines\/chemokines in urinary bladder inflammation and dysfunction. Biomed Res Int. 2014, 2014:120525. 10.1155\/2014\/120525","journal-title":"Biomed Res Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/iju.12685","article-title":"Status of urological Kampo medicine: a narrative review and future vision","volume":"22","author":"Minagawa T","year":"2015","unstructured":"Minagawa T, Ishizuka O. Status of urological Kampo medicine: a narrative review and future vision. Int J Urol. 2015, 22:254-63. 10.1111\/iju.12685","journal-title":"Int J Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/luts.12302","article-title":"Therapeutic effects of Choreito, a traditional Japanese (Kampo) medicine, on detrusor overactivity induced by acetic acid in rats","volume":"12","author":"Ueno M","year":"2020","unstructured":"Ueno M, Minagawa T, Saito T, Imamura T, Nagai T, Ogawa T, Ishizuka O. Therapeutic effects of Choreito, a traditional Japanese (Kampo) medicine, on detrusor overactivity induced by acetic acid in rats. Low Urin Tract Symptoms. 2020, 12:198-205. 10.1111\/luts.12302","journal-title":"Low Urin Tract Symptoms"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/tkm2.1386","article-title":"A review of frequently used Kampo prescriptions. Part 3. Yokukansan","volume":"2023","author":"Yamaguchi H","year":"2023","unstructured":"Yamaguchi H, Yoshino T, Oizumi H, Arita R, Nogami T, Takayama S. A review of frequently used Kampo prescriptions. Part 3. Yokukansan. Traditional & Kampo Medicine. 2023, 2023:1-27. 10.1002\/tkm2.1386","journal-title":"Traditional & Kampo Medicine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017000","article-title":"Effectiveness of the traditional Japanese Kampo medicine Yokukansan for chronic migraine: a case report","volume":"98","author":"Akiyama H","year":"2019","unstructured":"Akiyama H, Hasegawa Y. Effectiveness of the traditional Japanese Kampo medicine Yokukansan for chronic migraine: a case report. Medicine (Baltimore). 2019, 98:e17000. 10.1097\/MD.0000000000017000","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00176","article-title":"Traditional Japanese herbal medicines for treatment of odontopathy","volume":"6","author":"Yamaguchi K","year":"2015","unstructured":"Yamaguchi K. Traditional Japanese herbal medicines for treatment of odontopathy. Front Pharmacol. 2015, 6:176. 10.3389\/fphar.2015.00176","journal-title":"Front Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/870687","article-title":"Yokukansan improves mechanical allodynia through the regulation of interleukin-6 expression in the spinal cord in mice with neuropathic pain","volume":"2015","author":"Ebisawa S","year":"2015","unstructured":"Ebisawa S, Andoh T, Shimada Y, Kuraishi Y. Yokukansan improves mechanical allodynia through the regulation of interleukin-6 expression in the spinal cord in mice with neuropathic pain. Evid Based Complement Alternat Med. 2015, 2015:870687. 10.1155\/2015\/870687","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2956920","article-title":"Yokukansan alleviates cancer pain by suppressing matrix metalloproteinase-9 in a mouse bone metastasis model","volume":"2019","author":"Nakao K","year":"2019","unstructured":"Nakao K, Fujiwara A, Komasawa N, et al.. Yokukansan alleviates cancer pain by suppressing matrix metalloproteinase-9 in a mouse bone metastasis model. Evid Based Complement Alternat Med. 2019, 2019:2956920. 10.1155\/2019\/2956920","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.862539","article-title":"Yokukansan inhibits the development of morphine tolerance by regulating presynaptic proteins in DRG neurons","volume":"13","author":"Ohashi Y","year":"2022","unstructured":"Ohashi Y, Sakhri FZ, Ikemoto H, Okumo T, Adachi N, Sunagawa M. Yokukansan inhibits the development of morphine tolerance by regulating presynaptic proteins in DRG neurons. Front Pharmacol. 2022, 13:862539. 10.3389\/fphar.2022.862539","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2012.09.079","article-title":"Yokukansan inhibits morphine tolerance and physical dependence in mice: the role of \u03b1\u2082A-adrenoceptor","volume":"227","author":"Nakagawa T","year":"2012","unstructured":"Nakagawa T, Nagayasu K, Nishitani N, et al.. Yokukansan inhibits morphine tolerance and physical dependence in mice: the role of \u03b1\u2082A-adrenoceptor. Neuroscience. 2012, 227:336-49. 10.1016\/j.neuroscience.2012.09.079","journal-title":"Neuroscience"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.705023","article-title":"Kampo formulae for the treatment of neuropathic pain \u223c especially the mechanism of action of Yokukansan","volume":"14","author":"Sunagawa M","year":"2021","unstructured":"Sunagawa M, Takayama Y, Kato M, et al.. Kampo formulae for the treatment of neuropathic pain \u223c especially the mechanism of action of Yokukansan. Front Mol Neurosci. 2021, 14:705023. 10.3389\/fnmol.2021.705023","journal-title":"Front Mol Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58060810","article-title":"The Japanese herbal medicine Yokukansan exerted antioxidant and analgesic effects in an experimental rat model of Hunner-type interstitial cystitis","volume":"58","author":"Inoue T","year":"2022","unstructured":"Inoue T, Tsukada M, Tsunokawa Y, et al.. The Japanese herbal medicine Yokukansan exerted antioxidant and analgesic effects in an experimental rat model of Hunner-type interstitial cystitis. Medicina (Kaunas). 2022, 58:810. 10.3390\/medicina58060810","journal-title":"Medicina (Kaunas)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2018.01.037","article-title":"Involvement of the cystathionine-\u03b3-lyase\/Ca(v)3.2 pathway in substance P-induced bladder pain in the mouse, a model for nonulcerative bladder pain syndrome","volume":"133","author":"Tsubota M","year":"2018","unstructured":"Tsubota M, Okawa Y, Irie Y, et al.. Involvement of the cystathionine-\u03b3-lyase\/Ca(v)3.2 pathway in substance P-induced bladder pain in the mouse, a model for nonulcerative bladder pain syndrome. Neuropharmacology. 2018, 133:254-63. 10.1016\/j.neuropharm.2018.01.037","journal-title":"Neuropharmacology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28634-0","article-title":"Neuroepithelial control of mucosal inflammation in acute cystitis","volume":"8","author":"Butler DS","year":"2018","unstructured":"Butler DS, Ambite I, Nagy K, et al.. Neuroepithelial control of mucosal inflammation in acute cystitis. Sci Rep. 2018, 8:11015. 10.1038\/s41598-018-28634-0","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000947","article-title":"Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain","volume":"158","author":"Ichihara K","year":"2017","unstructured":"Ichihara K, Aizawa N, Akiyama Y, et al.. Toll-like receptor 7 is overexpressed in the bladder of Hunner-type interstitial cystitis, and its activation in the mouse bladder can induce cystitis and bladder pain. Pain. 2017, 158:1538-45. 10.1097\/j.pain.0000000000000947","journal-title":"Pain"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.09.046","article-title":"Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes","volume":"626","author":"Kawakami Z","year":"2010","unstructured":"Kawakami Z, Ikarashi Y, Kase Y. Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes. Eur J Pharmacol. 2010, 626:154-8. 10.1016\/j.ejphar.2009.09.046","journal-title":"Eur J Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-011-9722-1","article-title":"Isoliquiritigenin is a novel NMDA receptor antagonist in Kampo medicine Yokukansan","volume":"31","author":"Kawakami Z","year":"2011","unstructured":"Kawakami Z, Ikarashi Y, Kase Y. Isoliquiritigenin is a novel NMDA receptor antagonist in Kampo medicine Yokukansan. Cell Mol Neurobiol. 2011, 31:1203-12. 10.1007\/s10571-011-9722-1","journal-title":"Cell Mol Neurobiol"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1254\/jphs.11079SC","article-title":"Yokukansan enhances pentobarbital-induced sleep in socially isolated mice: possible involvement of GABA(A) - benzodiazepine receptor complex","volume":"116","author":"Egashira N","year":"2011","unstructured":"Egashira N, Nogami A, Iwasaki K, et al.. Yokukansan enhances pentobarbital-induced sleep in socially isolated mice: possible involvement of GABA(A) - benzodiazepine receptor complex. J Pharmacol Sci. 2011, 116:316-20.","journal-title":"J Pharmacol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2012.07.007","article-title":"Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress","volume":"143","author":"Yamaguchi T","year":"2012","unstructured":"Yamaguchi T, Tsujimatsu A, Kumamoto H, Izumi T, Ohmura Y, Yoshida T, Yoshioka M. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. J Ethnopharmacol. 2012, 143:533-9. 10.1016\/j.jep.2012.07.007","journal-title":"J Ethnopharmacol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.17-59","article-title":"Clinical significance of redox effects of Kampo formulae, a traditional Japanese herbal medicine: comprehensive estimation of multiple antioxidative activities","volume":"62","author":"Hirayama A","year":"2018","unstructured":"Hirayama A, Oowada S, Ito H, Matsui H, Ueda A, Aoyagi K. Clinical significance of redox effects of Kampo formulae, a traditional Japanese herbal medicine: comprehensive estimation of multiple antioxidative activities. J Clin Biochem Nutr. 2018, 62:39-48. 10.3164\/jcbn.17-59","journal-title":"J Clin Biochem Nutr"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.01.021","article-title":"Substance P represents a novel first-line defense mechanism in the nose","volume":"141","author":"Larsson O","year":"2018","unstructured":"Larsson O, Tengroth L, Xu Y, Uddman R, Kumlien Geor\u00e9n S, Cardell LO. Substance P represents a novel first-line defense mechanism in the nose. J Allergy Clin Immunol. 2018, 141:128-136.e3. 10.1016\/j.jaci.2017.01.021","journal-title":"J Allergy Clin Immunol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/molecules17010716","article-title":"Evaluation of the immunity activity of glycyrrhizin in AR mice","volume":"17","author":"Li XL","year":"2012","unstructured":"Li XL, Zhou AG. Evaluation of the immunity activity of glycyrrhizin in AR mice. Molecules. 2012, 17:716-27. 10.3390\/molecules17010716","journal-title":"Molecules"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/pm.pm_126_17","article-title":"Comparison of bran-processed and crude Atractylodes lancea effects on spleen deficiency syndrome in rats","volume":"14","author":"Xue DH","year":"2018","unstructured":"Xue DH, Liu YQ, Cai Q, Liang K, Zheng BY, Li FX, Pang X. Comparison of bran-processed and crude Atractylodes lancea effects on spleen deficiency syndrome in rats. Pharmacogn Mag. 2018, 14:214-9. 10.4103\/pm.pm_126_17","journal-title":"Pharmacogn Mag"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134803","article-title":"Presence of cleaved synaptosomal-associated protein-25 and decrease of purinergic receptors P2X3 in the bladder urothelium influence efficacy of botulinum toxin treatment for overactive bladder syndrome","volume":"10","author":"Liu HT","year":"2015","unstructured":"Liu HT, Chen SH, Chancellor MB, Kuo HC. Presence of cleaved synaptosomal-associated protein-25 and decrease of purinergic receptors P2X3 in the bladder urothelium influence efficacy of botulinum toxin treatment for overactive bladder syndrome. PLoS One. 2015, 10:e0134803. 10.1371\/journal.pone.0134803","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/218946-analgesic-effect-of-the-kampo-formula-yokukansan-via-the-suppression-of-substance-p-in-an-experimental-rat-model-of-hunner-type-interstitial-cystitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:01Z","timestamp":1707509641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/218946-analgesic-effect-of-the-kampo-formula-yokukansan-via-the-suppression-of-substance-p-in-an-experimental-rat-model-of-hunner-type-interstitial-cystitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.52238","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,14]]}}}